1. Office for Life Sciences. Press release. Lord O’Shaughnessy to lead independent review into UK clinical trials. 20 February 2023. https://www.gov.uk/government/news/lord-oshaughnessy-to-lead-independent-review-into-uk-clinical-trials.
2. Association of the British Pharmaceutical Industry. Rescuing patient access to industry clinical trials in the UK. 20 October 2022. https://www.abpi.org.uk/publications/rescuing-the-uk-industry-clinical-trials.
3. Phase II and Phase III attrition rates 2011–2012
4. Regulatory policy and pharmaceutical innovation in the United Kingdom after Brexit: Initial insights
5. Department of Health and Social Care, Department for Science, Innovation and Technology, and Office for Life Sciences. Independent report. Commercial clinical trials in the UK: the Lord O’Shaughnessy review. 25 May 2023. https://www.gov.uk/government/publications/commercial-clinical-trials-in-the-uk-the-lord-oshaughnessy-review.